Glyburide, a K+ATP channel blocker, improves hypotension and survival in anaphylactic shock induced in Wistar rats sensitized to ovalbumin

Subramanian Dhanasekaran, Abderrahim Nemmar, Elhadi H. Aburawi, Elsadig E. Kazzam, Abdishakur Abdulle, Moufida Bellou, Abdelouahab Bellou

Research output: Contribution to journalArticle

Abstract

Allergens can induce anaphylactic shock and death due to severe hypotension. Potassium channel blockers (K+ATP) such as glyburide (GLY) induce vasoconstriction. The effect of K+ ATP channel blockers on anaphylactic shock is poorly understood. Objective of the study was to test the hypothesis that GLY reduces hypotension induced in anaphylactic shock and increases survival. Rats were grouped into: G1-N=Naïve; G2-SC=Sensitized-Control; G3-SG=Sensitized-GLY (glyburide 40 mg/kg); G4-SE=Sensitized-EPI (epinephrine 10 μg/kg). G2 to G4 groups were sensitized with ovalbumin (OVA) and shock was induced by i.v. injection of OVA. Treatments were administered intravenously 5 min later. Mean arterial pressure (MAP), heart rate (HR), and mean survival time (MST) were measured for 60 min following OVA injection and treatments administration. At the end of the experiment, blood withdrawal was performed to measure plasma levels of histamine, leukotriene B4 (LTB4), prostaglandin E 2 (PGE2) and prostaglandin F2 (PGF 2). Additionally blood gas (paO2, p aCO2, SaO2) and electrolytes (Na+, K+ and Ca++) were measured. MAP was normal in G1-N; severe hypotension, negative inotropic and short MST were observed in G2-SC; normalization of MAP, with lesser negative inotropism and increased MST were observed in G3-SG; full recovery was observed in G4-SE. Histamine level was significantly higher in G2-SC; reduced in G3-SG and G4-SE. PGE2 increased in G3-SG; PGF2 increased in G2-SC and G3-SG. Na+ and Ca++ concentration decreased in sensitized rats but reversed in treated groups, without change in K+ concentration. In conclusion, our data suggest that administration of GLY reduces hypotension and increases survival time in rat anaphylactic shock.

Original languageEnglish (US)
Pages (from-to)166-173
Number of pages8
JournalEuropean Journal of Pharmacology
Volume720
Issue number1-3
DOIs
StatePublished - Nov 15 2013

Fingerprint

Glyburide
Ovalbumin
Anaphylaxis
Hypotension
Wistar Rats
Adenosine Triphosphate
Arterial Pressure
Dinoprost
Prostaglandins E
Histamine
Controlled Hypotension
Potassium Channel Blockers
Injections
Leukotriene B4
Muscle Contraction
Vasoconstriction
Allergens
Electrolytes
Epinephrine
Shock

Keywords

  • Anaphylactic shock
  • Eicosanoids
  • Glyburide
  • Histamine
  • K channel blockers
  • Ovalbumin
  • Prostanoids

ASJC Scopus subject areas

  • Pharmacology

Cite this

Glyburide, a K+ATP channel blocker, improves hypotension and survival in anaphylactic shock induced in Wistar rats sensitized to ovalbumin. / Dhanasekaran, Subramanian; Nemmar, Abderrahim; Aburawi, Elhadi H.; Kazzam, Elsadig E.; Abdulle, Abdishakur; Bellou, Moufida; Bellou, Abdelouahab.

In: European Journal of Pharmacology, Vol. 720, No. 1-3, 15.11.2013, p. 166-173.

Research output: Contribution to journalArticle

Dhanasekaran, Subramanian ; Nemmar, Abderrahim ; Aburawi, Elhadi H. ; Kazzam, Elsadig E. ; Abdulle, Abdishakur ; Bellou, Moufida ; Bellou, Abdelouahab. / Glyburide, a K+ATP channel blocker, improves hypotension and survival in anaphylactic shock induced in Wistar rats sensitized to ovalbumin. In: European Journal of Pharmacology. 2013 ; Vol. 720, No. 1-3. pp. 166-173.
@article{66074e69758d4cbc86b14f6d30853ab9,
title = "Glyburide, a K+ATP channel blocker, improves hypotension and survival in anaphylactic shock induced in Wistar rats sensitized to ovalbumin",
abstract = "Allergens can induce anaphylactic shock and death due to severe hypotension. Potassium channel blockers (K+ATP) such as glyburide (GLY) induce vasoconstriction. The effect of K+ ATP channel blockers on anaphylactic shock is poorly understood. Objective of the study was to test the hypothesis that GLY reduces hypotension induced in anaphylactic shock and increases survival. Rats were grouped into: G1-N=Na{\"i}ve; G2-SC=Sensitized-Control; G3-SG=Sensitized-GLY (glyburide 40 mg/kg); G4-SE=Sensitized-EPI (epinephrine 10 μg/kg). G2 to G4 groups were sensitized with ovalbumin (OVA) and shock was induced by i.v. injection of OVA. Treatments were administered intravenously 5 min later. Mean arterial pressure (MAP), heart rate (HR), and mean survival time (MST) were measured for 60 min following OVA injection and treatments administration. At the end of the experiment, blood withdrawal was performed to measure plasma levels of histamine, leukotriene B4 (LTB4), prostaglandin E 2 (PGE2) and prostaglandin F2 (PGF 2). Additionally blood gas (paO2, p aCO2, SaO2) and electrolytes (Na+, K+ and Ca++) were measured. MAP was normal in G1-N; severe hypotension, negative inotropic and short MST were observed in G2-SC; normalization of MAP, with lesser negative inotropism and increased MST were observed in G3-SG; full recovery was observed in G4-SE. Histamine level was significantly higher in G2-SC; reduced in G3-SG and G4-SE. PGE2 increased in G3-SG; PGF2 increased in G2-SC and G3-SG. Na+ and Ca++ concentration decreased in sensitized rats but reversed in treated groups, without change in K+ concentration. In conclusion, our data suggest that administration of GLY reduces hypotension and increases survival time in rat anaphylactic shock.",
keywords = "Anaphylactic shock, Eicosanoids, Glyburide, Histamine, K channel blockers, Ovalbumin, Prostanoids",
author = "Subramanian Dhanasekaran and Abderrahim Nemmar and Aburawi, {Elhadi H.} and Kazzam, {Elsadig E.} and Abdishakur Abdulle and Moufida Bellou and Abdelouahab Bellou",
year = "2013",
month = "11",
day = "15",
doi = "10.1016/j.ejphar.2013.10.031",
language = "English (US)",
volume = "720",
pages = "166--173",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Glyburide, a K+ATP channel blocker, improves hypotension and survival in anaphylactic shock induced in Wistar rats sensitized to ovalbumin

AU - Dhanasekaran, Subramanian

AU - Nemmar, Abderrahim

AU - Aburawi, Elhadi H.

AU - Kazzam, Elsadig E.

AU - Abdulle, Abdishakur

AU - Bellou, Moufida

AU - Bellou, Abdelouahab

PY - 2013/11/15

Y1 - 2013/11/15

N2 - Allergens can induce anaphylactic shock and death due to severe hypotension. Potassium channel blockers (K+ATP) such as glyburide (GLY) induce vasoconstriction. The effect of K+ ATP channel blockers on anaphylactic shock is poorly understood. Objective of the study was to test the hypothesis that GLY reduces hypotension induced in anaphylactic shock and increases survival. Rats were grouped into: G1-N=Naïve; G2-SC=Sensitized-Control; G3-SG=Sensitized-GLY (glyburide 40 mg/kg); G4-SE=Sensitized-EPI (epinephrine 10 μg/kg). G2 to G4 groups were sensitized with ovalbumin (OVA) and shock was induced by i.v. injection of OVA. Treatments were administered intravenously 5 min later. Mean arterial pressure (MAP), heart rate (HR), and mean survival time (MST) were measured for 60 min following OVA injection and treatments administration. At the end of the experiment, blood withdrawal was performed to measure plasma levels of histamine, leukotriene B4 (LTB4), prostaglandin E 2 (PGE2) and prostaglandin F2 (PGF 2). Additionally blood gas (paO2, p aCO2, SaO2) and electrolytes (Na+, K+ and Ca++) were measured. MAP was normal in G1-N; severe hypotension, negative inotropic and short MST were observed in G2-SC; normalization of MAP, with lesser negative inotropism and increased MST were observed in G3-SG; full recovery was observed in G4-SE. Histamine level was significantly higher in G2-SC; reduced in G3-SG and G4-SE. PGE2 increased in G3-SG; PGF2 increased in G2-SC and G3-SG. Na+ and Ca++ concentration decreased in sensitized rats but reversed in treated groups, without change in K+ concentration. In conclusion, our data suggest that administration of GLY reduces hypotension and increases survival time in rat anaphylactic shock.

AB - Allergens can induce anaphylactic shock and death due to severe hypotension. Potassium channel blockers (K+ATP) such as glyburide (GLY) induce vasoconstriction. The effect of K+ ATP channel blockers on anaphylactic shock is poorly understood. Objective of the study was to test the hypothesis that GLY reduces hypotension induced in anaphylactic shock and increases survival. Rats were grouped into: G1-N=Naïve; G2-SC=Sensitized-Control; G3-SG=Sensitized-GLY (glyburide 40 mg/kg); G4-SE=Sensitized-EPI (epinephrine 10 μg/kg). G2 to G4 groups were sensitized with ovalbumin (OVA) and shock was induced by i.v. injection of OVA. Treatments were administered intravenously 5 min later. Mean arterial pressure (MAP), heart rate (HR), and mean survival time (MST) were measured for 60 min following OVA injection and treatments administration. At the end of the experiment, blood withdrawal was performed to measure plasma levels of histamine, leukotriene B4 (LTB4), prostaglandin E 2 (PGE2) and prostaglandin F2 (PGF 2). Additionally blood gas (paO2, p aCO2, SaO2) and electrolytes (Na+, K+ and Ca++) were measured. MAP was normal in G1-N; severe hypotension, negative inotropic and short MST were observed in G2-SC; normalization of MAP, with lesser negative inotropism and increased MST were observed in G3-SG; full recovery was observed in G4-SE. Histamine level was significantly higher in G2-SC; reduced in G3-SG and G4-SE. PGE2 increased in G3-SG; PGF2 increased in G2-SC and G3-SG. Na+ and Ca++ concentration decreased in sensitized rats but reversed in treated groups, without change in K+ concentration. In conclusion, our data suggest that administration of GLY reduces hypotension and increases survival time in rat anaphylactic shock.

KW - Anaphylactic shock

KW - Eicosanoids

KW - Glyburide

KW - Histamine

KW - K channel blockers

KW - Ovalbumin

KW - Prostanoids

UR - http://www.scopus.com/inward/record.url?scp=84890114948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890114948&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2013.10.031

DO - 10.1016/j.ejphar.2013.10.031

M3 - Article

C2 - 24436988

AN - SCOPUS:84890114948

VL - 720

SP - 166

EP - 173

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -